Aveanna Healthcare (NASDAQ:AVAH) CFO Matthew Buckhalter Sells 9,351 Shares

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CFO Matthew Buckhalter sold 9,351 shares of Aveanna Healthcare stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $7.65, for a total transaction of $71,535.15. Following the completion of the sale, the chief financial officer owned 555,922 shares in the company, valued at approximately $4,252,803.30. This trade represents a 1.65% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Matthew Buckhalter also recently made the following trade(s):

• On Thursday, February 19th, Matthew Buckhalter sold 13,512 shares of Aveanna Healthcare stock. The stock was sold at an average price of $7.21, for a total transaction of $97,421.52.
• On Wednesday, February 18th, Matthew Buckhalter sold 13,167 shares of Aveanna Healthcare stock. The shares were sold at an average price of $7.38, for a total transaction of $97,172.46.
• On Friday, January 2nd, Matthew Buckhalter sold 18,340 shares of Aveanna Healthcare stock. The stock was sold at an average price of $7.85, for a total value of $143,969.00.
• On Wednesday, December 31st, Matthew Buckhalter sold 17,289 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.18, for a total value of $141,424.02.
• On Tuesday, December 30th, Matthew Buckhalter sold 17,448 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.36, for a total value of $145,865.28.

Aveanna Healthcare Price Performance

Shares of NASDAQ:AVAH traded up $0.02 during trading on Thursday, reaching $7.42. The stock had a trading volume of 3,877,110 shares, compared to its average volume of 938,081. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23. Aveanna Healthcare Holdings Inc. has a 1-year low of $3.67 and a 1-year high of $10.32. The stock has a market cap of $1.55 billion, a PE ratio of 20.61 and a beta of 2.06. The business has a fifty day moving average price of $8.48 and a 200-day moving average price of $8.44.

Hedge Funds Weigh In On Aveanna Healthcare

Institutional investors have recently bought and sold shares of the company. Quantbot Technologies LP purchased a new stake in shares of Aveanna Healthcare in the 2nd quarter valued at approximately $43,000. MQS Management LLC purchased a new stake in shares of Aveanna Healthcare during the 2nd quarter valued at approximately $59,000. Belvedere Trading LLC acquired a new position in Aveanna Healthcare in the second quarter valued at approximately $62,000. Oxford Asset Management LLP purchased a new position in Aveanna Healthcare in the second quarter worth approximately $64,000. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in Aveanna Healthcare during the second quarter worth $68,000. 87.96% of the stock is owned by hedge funds and other institutional investors.

Aveanna Healthcare News Roundup

Here are the key news stories impacting Aveanna Healthcare this week:

• Neutral Sentiment: Short-interest data released for Feb. 19 shows an apparent data anomaly (0 shares reported / NaN change), so there’s no clear short‑interest signal to explain price moves today. (Report notes the short‑interest ratio is effectively 0 days based on reported volume.)
• Neutral Sentiment: Market commentary explains recent intraday weakness in AVAH; see a recent write‑up for context on why the stock moved. Why AVAH is Down
• Negative Sentiment: Significant insider selling: over Feb. 17–19 multiple insiders (CEO Jeff Shaner, several executives including CFO Matthew Buckhalter and CAO Deborah Stewart, plus others such as Edwin C. Reisz and Patrick A. Cunningham) sold large blocks. Combined, these filings show roughly 740,000 shares sold across the group — about $5.4–$5.5M in proceeds — at average prices in the ~$7.20–$7.65 range. Collective, high‑profile sales of this size often weigh on near‑term investor sentiment because they increase supply and may be interpreted as insiders taking money off the table. CEO Filings Other Exec Filings

Analysts Set New Price Targets

A number of equities research analysts have recently commented on AVAH shares. BMO Capital Markets began coverage on shares of Aveanna Healthcare in a research report on Thursday, November 13th. They issued an “outperform” rating and a $11.00 target price for the company. Royal Bank Of Canada boosted their price target on shares of Aveanna Healthcare from $10.00 to $11.00 and gave the stock a “sector perform” rating in a research report on Thursday, January 15th. William Blair started coverage on shares of Aveanna Healthcare in a report on Monday, December 8th. They issued an “outperform” rating for the company. Raymond James Financial reissued an “outperform” rating and issued a $13.00 target price on shares of Aveanna Healthcare in a research note on Friday, December 5th. Finally, Jefferies Financial Group boosted their target price on Aveanna Healthcare from $11.00 to $12.50 and gave the stock a “buy” rating in a report on Tuesday, October 28th. Five research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $11.06.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.